Biofire reagents and extended warranties for maintenance - cheyenne and musk call order
Ended Awarded Last action
- Contract number
- 36C25924N0035
- Awardee
-
Biofire Diagnostics LLC UEI TBBNREFT3LD3
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $227,722
Award facts
- Contract value 100% obligated
- $227,722.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Cheyenne, WY, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$45,154 | |
| Supplemental Agreement for work within scope | $80,000 | |
| Original award | $192,876 |
About this award
This contract award represents a call order issued under a Blanket Purchase Agreement between the Department of Veterans Affairs, Veterans Integrated Service Network 19 (VISN 19), and Biofire Diagnostics LLC for the provision of BioFire reagents and extended maintenance warranties supporting diagnostic operations at facilities in Cheyenne, Wyoming and Muskogee, Oklahoma. The award, issued on October 1, 2023, carries a ceiling value of $227,722 and is structured as a firm fixed-price call order under an existing BPA vehicle. This procurement supports the VA's delivery of healthcare services to veterans by supplying reagents for the BioFire FilmArray diagnostic system, which enables rapid molecular detection of multiple pathogens from clinical samples across respiratory, gastrointestinal, bloodstream, and meningitis testing applications. The contract is not designated as a set-aside and represents a continuation of Biofire Diagnostics' ongoing relationship with VISN 19, which maintains a larger $4.83 million BPA with the company for reagents and equipment maintenance.
Biofire Diagnostics LLC, a biotechnology company specializing in advanced molecular diagnostic solutions, was selected as the awardee based on its established GSA Federal Supply Schedule contract for in-vitro diagnostics. The ultimate completion date is set for September 30, 2024, and performance will occur at the specified VA facilities in Wyoming and Oklahoma. As a proven federal contractor with no set-aside designation, Biofire Diagnostics demonstrates competitive positioning in the federal diagnostic products marketplace and provides critical laboratory capabilities that support the VA's mission to deliver comprehensive healthcare to the veteran population.
Quick answers
Who was awarded contract 36C25924N0035?
36C25924N0035 was awarded to Biofire Diagnostics LLC by Veterans Integrated Service Network 19 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C25924N0035 worth?
The government has obligated $227,722 on 36C25924N0035.
Is contract 36C25924N0035 an order under another contract?
Yes. 36C25924N0035 is a BPA call under 36C25921A0064, a blanket purchase agreement.
Was contract 36C25924N0035 competed?
The extent of competition for 36C25924N0035 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award